Drugs / HAT01H
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03089229 | Mar → Jun 2017 | atopic eczema | Haus Bioceuticals | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAT01H | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03089229 ↗ |
| Route | Topical | “This topical medicated cream will be applied once in the morning and once in the evening at least 8 hours apart to all lesions.” NCT03089229 ↗ |